Clinical trials sponsored by Hansoh BioMedical R&D Company

Phase breakdown

Conditions studied

Recruiting trials led by Hansoh BioMedical R&D Company

• A Phase Ib/II Trial of HS-20110 Combination Therapies in Advanced Colorectal Cancer Patients.
  NCT07283367 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Study of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung Cancer
  NCT06417008 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• ARTEMIS-102: HS-20093 Combinations in Patients with Advanced Metastatic Colorectal Cancer
  NCT06825624 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis
  NCT06176508 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Phase Ib Study of HS-20093+HRS-5041 in Patients With Advanced Prostate Cancer
  NCT07115446 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · 1 location
• Phase Ib Trial of HS-20117 in Combination With Other Drugs in Advanced Solid Tumors
  NCT06621563 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Hansoh BioMedical R&D Company recruiting for?

Hansoh BioMedical R&D Company is the lead sponsor of 6 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.